Gene: MFN1
Official Full Name: mitofusin 1provided by HGNC
Gene Summary: The protein encoded by this gene is a mediator of mitochondrial fusion. This protein and mitofusin 2 are homologs of the Drosophila protein fuzzy onion (Fzo). They are mitochondrial membrane proteins that interact with each other to facilitate mitochondrial targeting. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00409 | MFN1 Knockout cell line (HEK293) | Human | MFN1 | 1:3~1:6 | Negative | Online Inquiry |
KO16206 | MFN1 Knockout cell line (HeLa) | Human | MFN1 | 1:3~1:6 | Negative | Online Inquiry |
KO16207 | MFN1 Knockout cell line (HCT 116) | Human | MFN1 | 1:2~1:4 | Negative | Online Inquiry |
KO16208 | MFN1 Knockout cell line (A549) | Human | MFN1 | 1:3~1:4 | Negative | Online Inquiry |
MFN1 Gene Knockout Cell Lines are specialized cellular models designed to facilitate the study of mitochondrial dynamics and associated metabolic pathways. Generated through advanced CRISPR/Cas9 gene editing technology, these knockout cell lines lack the MFN1 gene, which encodes mitofusin 1—an integral protein involved in the fusion of mitochondria. By creating a controlled genetic background devoid of this key component, researchers can meticulously investigate the role of MFN1 in cellular processes, including mitochondrial morphology, bioenergetics, and apoptosis.
The central function of MFN1 involves mediating mitochondrial fusion, thus playing a crucial role in maintaining mitochondrial integrity and function. In the absence of MFN1, cells exhibit fragmented mitochondria and altered energy metabolism, creating a valuable model for studying various pathologies, including neurodegenerative diseases, metabolic disorders, and cancer. By utilizing these knockout cell lines, researchers can elucidate the molecular mechanisms underlying mitochondrial dysfunction, pave the way for drug discovery, and enhance our understanding of mitochondrial-related diseases.
What distinguishes MFN1 Gene Knockout Cell Lines from alternatives is the precision of gene disruption facilitated by CRISPR technology, combined with comprehensive validation of the knockout. This leads to more reproducible results, making these cell lines essential for both inquiry-driven research and translational applications in clinical settings.
The value of these knockout cell lines lies in their potential to drive breakthroughs in the understanding of mitochondrial biology, particularly in complex disease contexts. Researchers and clinicians seeking to unravel the complexities of mitochondrial dynamics can leverage these models to advance their studies.
Our company is dedicated to providing high-quality biological products backed by rigorous scientific research and expertise, empowering scientists worldwide in their quest for innovative solutions. With MFN1 Gene Knockout Cell Lines, we affirm our commitment to advancing understanding in cellular biology and disease mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.